0001140361-24-013494.txt : 20240315
0001140361-24-013494.hdr.sgml : 20240315
20240315160523
ACCESSION NUMBER: 0001140361-24-013494
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240308
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flynn Sean C.
CENTRAL INDEX KEY: 0001801993
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 24754690
MAIL ADDRESS:
STREET 1: C/O VERICEL CORPORATION
STREET 2: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4/A
1
form4.xml
FORM 4/A
X0508
4/A
2024-03-08
2024-03-11
0000887359
Vericel Corp
VCEL
0001801993
Flynn Sean C.
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
SVP, General Counsel
true
Common Stock
2024-03-08
4
S
0
8115
45.33
D
167
D
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2023.
These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
On March 11, 2024, a Form 4 was filed reporting a sale of 8,115 shares for the reporting person. The sale was conducted pursuant to a Rule 10b5-1(c) plan, however, the Rule 10b5-1(c) Transaction Indication was inadvertently not checked. This Form 4/A is being filed to correct the error, and reflects the sale of 8,115 shares pursuant to the reporting person's Rule 10b5-1(c) plan.
/s/ Sean Flynn
2024-03-15